重庆招聘

职位描述：
Key areas of responsibilty:
    Take on the rsponsibility of leading clinical data from site to achieve deliverables within agreed timelines and in accordance with scientific,quality and/or requlatory requireents.
    Serve as the point person between the hospitals and the clinical team.
    Support the design of data collection tools and relevant management forms.
    Work with the scientific data managemnt team to test and implement improvements to the data reporting system.
    Assist in review of raw data or patient profiles through data listing and resolve queries.
    Be responsible for medical and scientific content of clinical documents directed toward hospital audience.
    Present medical and scientific content to customers via phone,in person or on line.
Qualifications(minimum requirements):
    High degree of trust-confidence.
    Stong ledership and excellent team player
    Stong stewadship skills(written and verbal) in local language
    Excellent understanding of the clinical developent process ,relevet diseaes and therapies,and the medical practice
Eucation:
    Bachelor's degree or above of medical or pharmaceutical science
Professional experience:
    No
Supplementary job description:
Degree of independent decisions:
    Ability to work independently to make decision and problem solving
Level of independence,innovation and initiative:
    Independence,innovation and initiative should always be demonstrated when analysing,prioritising,planning and performing tasks either assigned by management or initiated by one self.
Main stakeholders/reputation and results:
Internal:team members from clinical,medical ,scientific,sales and R&D funcaional groups
External:All the healthcare professionals,doctors,KOL,vender responsible person,CRO
Communication/Interaction with others internally or externally:
    Serve as a focal point of communication between the clinical team and various functions,Communicate to doctors
    update project progress and potential critical issues and report to management level 举报 分享

关于燃石医学
燃石医学（纳斯达克代码：BNR）成立于2014年，公司使命为“用科学守护生命之光”，专注于为肿瘤精准医疗提供具有临床价值的二代基因测序（NGS）。公司业务及研发方向主要覆盖：1）基于NGS的肿瘤患病人群检测，6年间，燃石累计检测样本超过18.5万例，在中国市场份额领跑行业；2）基于NGS的癌症早检，目前已经进入临床验证阶段。
燃石医学于2018年7月率先获国家药品监督管理局（NMPA）颁发的中国肿瘤NGS检测试剂盒，在体外诊断领域具有里程碑式意义。实验室获得广东省临检中心颁发的 “高通量测序实验室”技术审核，以及得美国CLIA和CAP实验室质量体系资质认证。公司将继续致力于开发创新可靠的NGS检测产品，推动肿瘤精准医疗领域的发展。

About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 185,000 tissue and liquid-based tests completed cumulatively, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
In July 2018, Burning Rock received the first approval for a tumor NGS kit by the National Medical Products Administration (NMPA), which is a significant milestone in the field of in vitro diagnosis in China. Burning Rock’s laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification. The company continues to be committed to the development of innovative and reliable NGS testing products and promoting the development of precision medicine in oncology.